August 29, 2024

 

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention: Daniel Crawford

 

 

Re:

BioCardia, Inc.

   

Registration Statement on Form S-1
   

File No. 333-281448

 

Acceleration Request

 

 

Requested Date:

August 29, 2024
  Requested Time:

4:30 p.m. Eastern Time

         

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281448) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.

 

 

 Sincerely,

 
     
  BIOCARDIA, INC.  

 

 

 

 

 

 

 

 

 

By:

/s/ David McClung

 

 

 

 David McClung

 

 

 

 Chief Financial Officer

 

 

 

cc:

Peter Altman, Ph.D., BioCardia, Inc.
  Austin D. March, Wilson Sonsini Goodrich & Rosati